The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:

To the Editor: We appreciate the comments of Dr. Waslick on our study. First, with regard to study subjects, DSM-IV criteria for bipolar I disorder, manic or mixed were required for both our study and the study conducted by Geller et al. However, Geller et al. also required subjects to have at least one cardinal symptom of elation and/or grandiosity. Also, Geller et al. redefined manic/hypomanic episodes in their study as the entire length of illness, whereas we used DSM-IV definitions for manic episodes. This may account for some differences between the two study groups. Second, in response to Dr. Waslick and Dr. Lysne et al., the investigators in the study had the option of discontinuing stimulants prior to randomization in this study if they thought that stimulants were exacerbating the subject’s mania. The presence of concurrent ADHD and stimulant treatment did not affect baseline ratings of psychopathology or treatment response.

Galveston, Tex.
Cincinnati, Ohio
Dallas, Tex.
Cleveland, Ohio
Boston, Mass.
East Hanover, N.J.
Malvern, Pa.
Baltimore, Md.
New Haven, Conn.
Oklahoma City, Okla.